ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
α-Synuclein (α-Syn) forms toxic intracellular protein inclusions and transmissible amyloid structures in Parkinson's disease (PD). Preventing α-Syn self-assembly has become one of the most promising approaches in the search for disease-modifying treatments for this neurodegenerative disorder. H...
| Autores: | , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2019 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:223739 |
| Acceso en línea: | https://ddd.uab.cat/record/223739 https://dx.doi.org/urn:doi:10.3389/fnmol.2019.00306 |
| Access Level: | acceso abierto |
| Palabra clave: | Parkinson's disease α-synuclein Amyloid Protein aggregation Aggregation inhibitor Caenorhabditis elegans Neurodegeneration |
| id |
ES_b4eae9d1fbab390c505e52604fff08cd |
|---|---|
| oai_identifier_str |
oai:ddd.uab.cat:223739 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerizationPeña Díaz, Samuel|||0000-0002-2902-823XPujols Pujol, Jordi|||0000-0001-9424-5866Conde Giménez, María|||0000-0003-4358-9110Carija, Anita|||0000-0001-5972-7448Dalfo, Esther|||0000-0003-4677-8515García, JesúsNavarro, Susanna|||0000-0001-8160-9536Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528Santos Suárez, Jaime|||0000-0001-9045-7765Salvatella, Xavier|||0000-0002-8371-4185Sancho Sanz, Javier|||0000-0002-2879-9200Ventura, Salvador|||0000-0002-9652-6351Parkinson's diseaseα-synucleinAmyloidProtein aggregationAggregation inhibitorCaenorhabditis elegansNeurodegenerationα-Synuclein (α-Syn) forms toxic intracellular protein inclusions and transmissible amyloid structures in Parkinson's disease (PD). Preventing α-Syn self-assembly has become one of the most promising approaches in the search for disease-modifying treatments for this neurodegenerative disorder. Here, we describe the capacity of a small molecule (ZPD-2), identified after a high-throughput screening, to inhibit α-Syn aggregation. ZPD-2 inhibits the aggregation of wild-type α-Syn and the A30P and H50Q familial variants in vitro at substoichiometric compound:protein ratios. In addition, the molecule prevents the spreading of α-Syn seeds in protein misfolding cyclic amplification assays. ZPD-2 is active against different α-Syn strains and blocks their seeded polymerization. Treating with ZPD-2 two different PD Caenorhabditis elegans models that express α-Syn either in muscle or in dopaminergic (DA) neurons substantially reduces the number of α-Syn inclusions and decreases synuclein-induced DA neurons degeneration. Overall, ZPD-2 is a hit compound worth to be explored in order to develop lead molecules for therapeutic intervention in PD. 22019-01-0120192019-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/223739https://dx.doi.org/urn:doi:10.3389/fnmol.2019.00306reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengEuropean Commission https://doi.org/10.13039/501100000780 648201Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 BIO2015-70092-RAgencia Estatal de Investigación https://doi.org/10.13039/501100011033 BIO2016-78310-RMinisterio de Economía y Competitividad https://doi.org/10.13039/501100003329 BFU2016-78232-Popen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2237392026-06-06T12:50:31Z |
| dc.title.none.fl_str_mv |
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization |
| title |
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization |
| spellingShingle |
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization Peña Díaz, Samuel|||0000-0002-2902-823X Parkinson's disease α-synuclein Amyloid Protein aggregation Aggregation inhibitor Caenorhabditis elegans Neurodegeneration |
| title_short |
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization |
| title_full |
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization |
| title_fullStr |
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization |
| title_full_unstemmed |
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization |
| title_sort |
ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization |
| dc.creator.none.fl_str_mv |
Peña Díaz, Samuel|||0000-0002-2902-823X Pujols Pujol, Jordi|||0000-0001-9424-5866 Conde Giménez, María|||0000-0003-4358-9110 Carija, Anita|||0000-0001-5972-7448 Dalfo, Esther|||0000-0003-4677-8515 García, Jesús Navarro, Susanna|||0000-0001-8160-9536 Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528 Santos Suárez, Jaime|||0000-0001-9045-7765 Salvatella, Xavier|||0000-0002-8371-4185 Sancho Sanz, Javier|||0000-0002-2879-9200 Ventura, Salvador|||0000-0002-9652-6351 |
| author |
Peña Díaz, Samuel|||0000-0002-2902-823X |
| author_facet |
Peña Díaz, Samuel|||0000-0002-2902-823X Pujols Pujol, Jordi|||0000-0001-9424-5866 Conde Giménez, María|||0000-0003-4358-9110 Carija, Anita|||0000-0001-5972-7448 Dalfo, Esther|||0000-0003-4677-8515 García, Jesús Navarro, Susanna|||0000-0001-8160-9536 Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528 Santos Suárez, Jaime|||0000-0001-9045-7765 Salvatella, Xavier|||0000-0002-8371-4185 Sancho Sanz, Javier|||0000-0002-2879-9200 Ventura, Salvador|||0000-0002-9652-6351 |
| author_role |
author |
| author2 |
Pujols Pujol, Jordi|||0000-0001-9424-5866 Conde Giménez, María|||0000-0003-4358-9110 Carija, Anita|||0000-0001-5972-7448 Dalfo, Esther|||0000-0003-4677-8515 García, Jesús Navarro, Susanna|||0000-0001-8160-9536 Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528 Santos Suárez, Jaime|||0000-0001-9045-7765 Salvatella, Xavier|||0000-0002-8371-4185 Sancho Sanz, Javier|||0000-0002-2879-9200 Ventura, Salvador|||0000-0002-9652-6351 |
| author2_role |
author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Parkinson's disease α-synuclein Amyloid Protein aggregation Aggregation inhibitor Caenorhabditis elegans Neurodegeneration |
| topic |
Parkinson's disease α-synuclein Amyloid Protein aggregation Aggregation inhibitor Caenorhabditis elegans Neurodegeneration |
| description |
α-Synuclein (α-Syn) forms toxic intracellular protein inclusions and transmissible amyloid structures in Parkinson's disease (PD). Preventing α-Syn self-assembly has become one of the most promising approaches in the search for disease-modifying treatments for this neurodegenerative disorder. Here, we describe the capacity of a small molecule (ZPD-2), identified after a high-throughput screening, to inhibit α-Syn aggregation. ZPD-2 inhibits the aggregation of wild-type α-Syn and the A30P and H50Q familial variants in vitro at substoichiometric compound:protein ratios. In addition, the molecule prevents the spreading of α-Syn seeds in protein misfolding cyclic amplification assays. ZPD-2 is active against different α-Syn strains and blocks their seeded polymerization. Treating with ZPD-2 two different PD Caenorhabditis elegans models that express α-Syn either in muscle or in dopaminergic (DA) neurons substantially reduces the number of α-Syn inclusions and decreases synuclein-induced DA neurons degeneration. Overall, ZPD-2 is a hit compound worth to be explored in order to develop lead molecules for therapeutic intervention in PD. |
| publishDate |
2019 |
| dc.date.none.fl_str_mv |
2 2019-01-01 2019 2019-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/223739 https://dx.doi.org/urn:doi:10.3389/fnmol.2019.00306 |
| url |
https://ddd.uab.cat/record/223739 https://dx.doi.org/urn:doi:10.3389/fnmol.2019.00306 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.relation.none.fl_str_mv |
European Commission https://doi.org/10.13039/501100000780 648201 Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 BIO2015-70092-R Agencia Estatal de Investigación https://doi.org/10.13039/501100011033 BIO2016-78310-R Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 BFU2016-78232-P |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869417299694321664 |
| score |
15,300724 |